Caris Life Sciences:
Precision medicine company utilizing proprietary platforms to provide oncologists with actionable treatment data for cancer and other complex diseases. Caris Molecular Intelligence® (CMI), is Caris’ patented genomic profiling molecular testing service currently on the market, a multi-technology diagnostic which assesses 592 genes, 53 RNA, and 12 proteins to provide a molecular blueprint for personalized oncology treatment. Extensive clinical outcomes database and bioinformatics capability.
Diagnostics Company /
Healthcare/Medical Diagnostics & Research
750 John Carpenter Freeway
Irving, Texas 7509
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.